Search clinical trials for: EV/DNG (SH T00658L)

Total 15 results

Bayer

Completed

Ovulation Inhibition of Two 4-phasic Oral Contraceptive Regimens

Ovulation Inhibition

Germany, Netherlands
Bayer

Completed

Study to Investigate Efficacy and Safety of a New Oral Contraceptive

Contraception

Germany, Austria, Spain
Bayer

Completed

Comparative Cycle Control Europe

Contraception

Germany, Czech Republic, France
Bayer

Completed

Impact of SH T00658ID as Compared to a Monophasic Contraceptive Containing Ethinylestradiol and Levonorgestrel (SH D01155E) on Hemostatic Parameters

Pregnancy, Unplanned

Netherlands
Bayer

Completed

Efficacy and Safety Study of an Oral Contraceptive in Healthy Females

Contraception

United States, Canada
Bayer

Completed

Qlaira rPMS (Regulatory Post Marketing Surveillance) Study in Korea

Contraception

Korea, Republic of
Bayer

Completed

Metabolism Study to Investigate the Impact of a Sequential Oral Contraceptive

Contraception

Germany
Bayer

Completed

Effects of SH T00658ID on Libido

Contraception | Libido

Belgium, Australia, Germany, Thailand, Spain, Austria, Italy
Bayer

Completed

Study of a 4-phasic Oral Contraceptive for the Treatment of Heavy Menstrual Bleeding

Metrorrhagia

China, Taiwan, Singapore, Philippines, Russian Federation, Thailand
Bayer

Completed

Qlaira Post-authorization Safety Study Related to Most Common Adverse Events in Mexican Women Who Wish to Avoid Pregnancy

Contraception

Mexico
Bayer

Completed

Efficacy and Safety of a Combined Oral Contraceptive of Estradiol Valerate and Dienogest in Healthy Female Subjects

Contraception

China, Taiwan, Thailand, India, Hong Kong
Bayer

Completed

Non-interventional Study on Oral Contraception Not Containing Ethinylestradiol (EE) to Assess Continuation Rates and Satisfaction

Contraceptives, Oral

Slovakia, France, Germany, Hungary, Sweden, Czech Republic, Italy, Russian Federation, United Kingdom, Greece, Israel
Bayer

Completed

Bioequivalence Study: 2 mg Estradiol Valerate (EV) and 3 mg Dienogest (DNG) Without and With Levomefolate Calcium

Pharmacology, Clinical

Germany
Bayer

Completed

Effect on Primary Dysmenorrhea

Primary Dysmenorrhea

Italy, Chile, United States, Philippines, Canada, Germany
Bayer

Completed

Effect of a New Oral Contraceptive Pill on Hormone Related Symptoms Such as Pelvic Pain and Headache

Headache | Pelvic Pain | Oral Contraceptive

Finland, France, Switzerland, Australia, Germany, Thailand, Mexico, United Kingdom, Spain

3

Subscribe